1159-57-5 Usage
Description
(2E)-1-(3-bromo-2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one is an organic compound belonging to the class of chalcones, characterized by a complex structure that includes a 3-bromo-2-hydroxy-4,6-dimethoxyphenyl group and a 3-phenylprop-2-en-1-one group. (2E)-1-(3-bromo-2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one is known for its potential biological activities and is of interest in pharmaceutical research and development.
Uses
Used in Pharmaceutical Research and Development:
(2E)-1-(3-bromo-2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-en-1-one is used as a compound of interest for its potential antioxidant, anti-inflammatory, anti-cancer, and antimicrobial properties. Its diverse biological activities make it a candidate for further study and development in the pharmaceutical industry for possible therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1159-57-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,5 and 9 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1159-57:
(6*1)+(5*1)+(4*5)+(3*9)+(2*5)+(1*7)=75
75 % 10 = 5
So 1159-57-5 is a valid CAS Registry Number.
1159-57-5Relevant articles and documents
Regioselective monobromination of (E)-1-(2′-hydroxy-4′, 6′-dimethoxyphenyl)-3-aryl-2-propen-1-ones using bromodimethylsulfonium bromide and synthesis of 8-bromoflavones and 7-bromoaurones
Khan, Abu T.,Choudhury, Abhik,Ali, Shahzad,Musawwer Khan, Md.
experimental part, p. 4852 - 4857 (2012/09/07)
A wide variety of monobrominated compounds 2a-l have been prepared in good yields from (E)-1-(2′-hydroxy-4′,6′-dimethoxyphenyl)-3-aryl-2- propen-1-ones (1a-l) through regioselective ring bromination using 1.5 equiv of bromodimethylsulfonium bromide (BDMS)
Synthesis of xanthoxyline derivatives with antinociceptive and antioedematogenic activities
Cechinel-Filho,Vaz,Zunino,Calixto,Yunes
, p. 833 - 839 (2007/10/03)
-